Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase II”

41,364 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41,364 results

Not applicableLooking for participantsNCT06051123
What this trial is testing

Effects of Probiotics in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Spectrum Disorder (ALS-FTDSD) Patients

Who this might be right for
ALSFTDALS (Amyotrophic Lateral Sclerosis)Frontal Temporal Dementia (FTD)
Centre hospitalier de l'Université de Montréal (CHUM) 150
Testing effectiveness (Phase 2)Study completedNCT03625323
What this trial is testing

Combination Study With Soluble LAG-3 Fusion Protein Eftilagimod Alpha (IMP321) and Pembrolizumab in Patients With Previously Untreated Unresectable or Metastatic NSCLC, or Recurrent PD-X Refractory NSCLC or With Recurrent or Metastatic HNSCC

Who this might be right for
NSCLCHNSCC
Immutep S.A.S. 187
Testing effectiveness (Phase 2)Study completedNCT02311582
What this trial is testing

MK-3475 in Combination With MRI-guided Laser Ablation in Recurrent Malignant Gliomas

Who this might be right for
Malignant Glioma
Washington University School of Medicine 55
Testing effectiveness (Phase 2)Study completedNCT00091182
What this trial is testing

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Extragonadal Germ Cell TumorChildhood Hepatoblastoma+23 more
National Cancer Institute (NCI) 180
Not applicableStudy completedNCT01797159
What this trial is testing

Hippocampal Prophylactic Cranial Irradiation for Small Cell Lung Cancer

Who this might be right for
Small-cell Lung CancerSCLCSmall Cell Lung Cancer Limited Stage
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Not applicableStudy completedNCT02308488
What this trial is testing

Study of Prone Accelerated Breast And Nodal IMRT

Who this might be right for
Lymphedema
NYU Langone Health 97
Testing effectiveness (Phase 2)Looking for participantsNCT05193227
What this trial is testing

Sustained Release Lidocaine for the Treatment of Postoperative Pain

Who this might be right for
Postoperative PainPostsurgical Pain
University of British Columbia 120
Large-scale testing (Phase 3)Ended earlyNCT00312442
What this trial is testing

Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy

Who this might be right for
Prostate Cancer
STEBA France 16
Testing effectiveness (Phase 2)Study completedNCT02054286
What this trial is testing

Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART).

Who this might be right for
HIV Infection
Theravectys S.A. 38
Large-scale testing (Phase 3)Not Yet RecruitingNCT07739186
What this trial is testing

A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tislelizumab Plus Platinum-doublet Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer(PANKU-Lung06)

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT03561870
What this trial is testing

Olaparib in Recurrent IDH-mutant Glioma

Who this might be right for
Recurrent IDHMutant High Grade Glioma
Hospices Civils de Lyon 35
Testing effectiveness (Phase 2)Study completedNCT00820170
What this trial is testing

Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT04792073
What this trial is testing

Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma

Who this might be right for
Merkel Cell Carcinoma
Memorial Sloan Kettering Cancer Center 18
Testing effectiveness (Phase 2)Looking for participantsNCT07222969
What this trial is testing

A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Vibrant Sciences Limited 146
Testing effectiveness (Phase 2)UnknownNCT02034669
What this trial is testing

Transplantation of Autologous Adipose Derived Stem Cells (ADSCs) in Spinal Cord Injury Treatment

Who this might be right for
Acute Spinal Cord Injury
Tri Phuoc Biotechnology., JSC 48
Testing effectiveness (Phase 2)Ended earlyNCT01625741
What this trial is testing

Phase II Study of High-Dose Rituximab in High-Risk Chronic Lymphocytic Leukemia Patients in Suboptimal Response After Induction Immunochemotherapy

Who this might be right for
Chronic Lymphocytic Leukemia
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 6
Testing effectiveness (Phase 2)WithdrawnNCT00256841
What this trial is testing

Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Clinical Oncology Research Associates
Early research (Phase 1)Ended earlyNCT03246854
What this trial is testing

DBPR112 in Patients With Head and Neck Cancer and EGFR Mutated Lung Cancer

Who this might be right for
Head and Neck CancerNSCLC
National Health Research Institutes, Taiwan 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07612254
What this trial is testing

APBI Re-irradiation

Who this might be right for
Breast Cancer Recurrent
Dartmouth-Hitchcock Medical Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT06419205
What this trial is testing

Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G

Who this might be right for
IgA NephropathyLupus Nephritis (LN)C3 (Complement Component 3) Glomerulopathy
Akebia Therapeutics 30
Next Page